AIM: To investigate our clinical experience with the colonic manifestations of phosphatase and tensin homolog on chromosome ten (PTEN) hamartoma tumor syndrome (PHTS) and to perform a systematic literature review regarding the same. METHODS: This study was approved by the appropriate institutional review board prior to initiation. A clinical genetics database was searched for patients with PHTS or a component syndrome that received gastrointestinal endoscopy or pathology interpretation at our center. These patient's records were retrospectively reviewed for clinical characteristics (including family history and genetic testing), endoscopy results and pathology findings. We also performed a systematic review of the literature for case series of PHTS or component syndromes that reported gastrointestinal manifestations and investigations published after consensus diagnostic criteria were established in 1996. These results were compiled and reported. RESULTS: Eight patients from our institution met initial inclusion criteria. Of these, 5 patients underwent 4.2 colonoscopies at mean age 45.8 ± 10.8 years. All were found to have colon polyps during their clinical course and polyp histology included adenoma, hyperplastic, ganglioneuroma and juvenile. No malignant lesions were identified. Two had multiple histologic types. One patient underwent colectomy due to innumerable polyps and concern for future malignant potential. Systematic literature review of PHTS patients undergoing endoscopy revealed 107 patients receiving colonoscopy at mean age 37.4 years. Colon polyps were noted in 92.5% and multiple colon polyp histologies were reported in 53.6%. Common polyp histologies included hyperplastic (43.6%), adenoma (40.4%), hamartoma (38.3%), ganglioneuroma (33%) and inflammatory (24.5%) polyps. Twelve (11.2%) patients had colorectal cancer at mean age 46.7 years (range 35-62). Clinical outcomes secondary to colon polyposis and malignancy were not commonly reported. CONCLUSION: PHTS has a high prevalence of colon polyposis with multiple histologic types. It should be considered a mixed polyposis syndrome. Systematic review found an increased prevalence of colorectal cancer and we recommend initiating colonoscopy for colorectal cancer surveillance at age 35 years.
AIM: To investigate our clinical experience with the colonic manifestations of phosphatase and tensin homolog on chromosome ten (PTEN) hamartoma tumor syndrome (PHTS) and to perform a systematic literature review regarding the same. METHODS: This study was approved by the appropriate institutional review board prior to initiation. A clinical genetics database was searched for patients with PHTS or a component syndrome that received gastrointestinal endoscopy or pathology interpretation at our center. These patient's records were retrospectively reviewed for clinical characteristics (including family history and genetic testing), endoscopy results and pathology findings. We also performed a systematic review of the literature for case series of PHTS or component syndromes that reported gastrointestinal manifestations and investigations published after consensus diagnostic criteria were established in 1996. These results were compiled and reported. RESULTS: Eight patients from our institution met initial inclusion criteria. Of these, 5 patients underwent 4.2 colonoscopies at mean age 45.8 ± 10.8 years. All were found to have colon polyps during their clinical course and polyp histology included adenoma, hyperplastic, ganglioneuroma and juvenile. No malignant lesions were identified. Two had multiple histologic types. One patient underwent colectomy due to innumerable polyps and concern for future malignant potential. Systematic literature review of PHTSpatients undergoing endoscopy revealed 107 patients receiving colonoscopy at mean age 37.4 years. Colon polyps were noted in 92.5% and multiple colon polyp histologies were reported in 53.6%. Common polyp histologies included hyperplastic (43.6%), adenoma (40.4%), hamartoma (38.3%), ganglioneuroma (33%) and inflammatory (24.5%) polyps. Twelve (11.2%) patients had colorectal cancer at mean age 46.7 years (range 35-62). Clinical outcomes secondary to colon polyposis and malignancy were not commonly reported. CONCLUSION:PHTS has a high prevalence of colon polyposis with multiple histologic types. It should be considered a mixed polyposis syndrome. Systematic review found an increased prevalence of colorectal cancer and we recommend initiating colonoscopy for colorectal cancer surveillance at age 35 years.
Entities:
Keywords:
Adenoma; Bannayan-Riley-Ruvalcaba syndrome; Colon polyps; Colorectal cancer; Cowden syndrome; Endoscopy; Ganglioneuroma; Hamartoma; Hyperplastic; Phosphatase and tensin homolog on chromosome ten
Authors: M R Nelen; W C van Staveren; E A Peeters; M B Hassel; R J Gorlin; H Hamm; C F Lindboe; J P Fryns; R H Sijmons; D G Woods; E C Mariman; G W Padberg; H Kremer Journal: Hum Mol Genet Date: 1997-08 Impact factor: 6.150
Authors: M G Butler; M J Dasouki; X-P Zhou; Z Talebizadeh; M Brown; T N Takahashi; J H Miles; C H Wang; R Stratton; R Pilarski; C Eng Journal: J Med Genet Date: 2005-04 Impact factor: 6.318
Authors: Kevin Sweet; Joseph Willis; Xiao-Ping Zhou; Carol Gallione; Takeshi Sawada; Pia Alhopuro; Sok Kean Khoo; Attila Patocs; Cossette Martin; Scott Bridgeman; John Heinz; Robert Pilarski; Rainer Lehtonen; Thomas W Prior; Thierry Frebourg; Bin Tean Teh; Douglas A Marchuk; Lauri A Aaltonen; Charis Eng Journal: JAMA Date: 2005-11-16 Impact factor: 56.272
Authors: D J Marsh; J B Kum; K L Lunetta; M J Bennett; R J Gorlin; S F Ahmed; J Bodurtha; C Crowe; M A Curtis; M Dasouki; T Dunn; H Feit; M T Geraghty; J M Graham; S V Hodgson; A Hunter; B R Korf; D Manchester; S Miesfeldt; V A Murday; K L Nathanson; M Parisi; B Pober; C Romano; C Eng Journal: Hum Mol Genet Date: 1999-08 Impact factor: 6.150
Authors: Brandie Heald; Jessica Mester; Lisa Rybicki; Mohammed S Orloff; Carol A Burke; Charis Eng Journal: Gastroenterology Date: 2010-06-27 Impact factor: 22.682
Authors: M H Nieuwenhuis; C M Kets; M Murphy-Ryan; C Colas; P Möller; F J Hes; S V Hodgson; M J W Olderode-Berends; S Aretz; K Heinimann; E B Gomez Garcia; F Douglas; A Spigelman; S Timshel; N M Lindor; H F A Vasen Journal: Colorectal Dis Date: 2012-09 Impact factor: 3.788
Authors: V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak Journal: Cell Date: 1998-10-02 Impact factor: 41.582
Authors: T M Starink; J P van der Veen; F Arwert; L P de Waal; G G de Lange; J J Gille; A W Eriksson Journal: Clin Genet Date: 1986-03 Impact factor: 4.438
Authors: Douglas L Riegert-Johnson; Ferga C Gleeson; Maegan Roberts; Krysta Tholen; Lauren Youngborg; Melvin Bullock; Lisa A Boardman Journal: Hered Cancer Clin Pract Date: 2010-06-17 Impact factor: 2.857
Authors: Sarah W DeParis; Michele Bloomer; Ying Han; M Reza Vagefi; Joseph T C Shieh; David A Solomon; James Grenert; Alejandra G de Alba Campomanes Journal: Ocul Oncol Pathol Date: 2016-11-22
Authors: Aybuke Caliskan; Wendy K Kohlmann; Kajsa E Affolter; Erinn Downs-Kelly; Priyanka Kanth; Mary P Bronner Journal: Mod Pathol Date: 2017-12-01 Impact factor: 7.842
Authors: Nicola Carlomagno; Francesca Duraturo; Maria Candida; Marina De Rosa; Valeria Varone; Giuseppe Ciancia; Armando Calogero; Michele L Santangelo Journal: J Med Case Rep Date: 2015-07-04
Authors: C Guillén-Ponce; R Serrano; A B Sánchez-Heras; A Teulé; I Chirivella; T Martín; E Martínez; R Morales; L Robles Journal: Clin Transl Oncol Date: 2015-11-19 Impact factor: 3.405